Long-term benzodiazepine use by elderly people living in the community.
OBJECTIVE
To investigate the prevalence of long-term benzodiazepine use in an elderly community sample, and factors associated with such use.


METHODS
Data came from the Sydney Older Persons Study, a longitudinal study of people aged 75 or over. There were 337 subjects who were interviewed in 1991-93, and subsequently followed up after three and 4.5 years. At the first interview, subjects were assessed for socio-demographic characteristics, physical and mental health, and use of health services. At the first and subsequent interviews, subjects were asked about use of medications, including benzodiazepines.


RESULTS
There were 16.6% who were using benzodiazepines at the time of all three interviews, while a further 19.6% were using them at one or two interviews. In a multivariate ordered logit regression model, long-term benzodiazepine use was associated with treatment for nervous conditions, restless sleep, being female, being divorced and greater contact with medical services.


CONCLUSIONS
The prevalence of benzodiazepine use in the elderly is high and much of this use is long term. The high prevalence of benzodiazepine use stands in contrast to the findings from national surveys that the elderly living in the community tend to have better mental health than younger age groups.


CONCLUSIONS
Efforts are needed to reduce the number of elderly people becoming long-term users. The use of benzodiazepines in this age group is of particular concern, because they may be a risk factor for falls and for cognitive impairment in the elderly.
Jorm
A F
AF
NHMRC Psychiatric Epidemiology Research Centre, Australian National University, Australian Capital Territory. Anthony.Jorm@anu.edu.au
Grayson
D
D
Creasey
H
H
Waite
L
L
Broe
G A
GA
D000368:Aged / Q000523:psychology / Q000706:statistics & numerical data*; D014151:Anti-Anxiety Agents / Q000627:therapeutic use*; D001007:Anxiety / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology; D001569:Benzodiazepines; D003863:Depression / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology; D004363:Drug Utilization; D005260:Female; D006296:Health Services / Q000706:statistics & numerical data*; D006304:Health Status; D006801:Humans; D016015:Logistic Models; D008137:Longitudinal Studies; D008297:Male; D009517:New South Wales / Q000453:epidemiology; D012307:Risk Factors; D012959:Socioeconomic Factors; D011795:Surveys and Questionnaires; D013997:Time Factors
D014151:Anti-Anxiety Agents; D001569:Benzodiazepines